Jazz Pharmaceuticals plc — Director's Dealing 2011

Feb 16, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2011-02-08

Reporting Person: DesJardin Michael A. (SVP, Product Development)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10371	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (right to buy)	$15.09	2014-09-14	Common Stock (13554)		Direct
Option (right to buy)	$16.60	2016-02-07	Common Stock (3163)		Direct
Option (right to buy)	$13.25	2017-08-12	Common Stock (25527)		Direct
Option (right to buy)	$7.96	2018-05-15	Common Stock (25000)		Direct
Option (right to buy)	$1.25	2019-01-20	Common Stock (70000)		Direct
Option (right to buy)	$11.48	2020-03-07	Common Stock (35000)		Direct
Restricted Stock Units	$	2011-08-13	Common Stock (709)		Direct

Footnotes

F1: This option vested over four years measured from the vesting commencement date, July 12, 2004, with 1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter.

F2: This option vested over four years measured from the vesting commencement date, February 8, 2006, in 48 equal monthly installments.

F3: This option vests over four years measured from the vesting commencement date, August 13, 2007, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.

F4: This option vests over four years measured from the vesting commencement date, May 7, 2008, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.

F5: This option vests over three years measured from the vesting commencement date, January 21, 2009, with 1/3rd vesting on the first anniversary of the vesting commencement date and the remainder vesting in 24 equal monthly installments thereafter.

F6: This option vests over four years measured from the vesting commencement date, March 8, 2010, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.

F7: 100% of the restricted stock units are scheduled to vest on August 13, 2011, assuming continued employment through the vesting date.

F8: Each restricted stock unit represents a contingent right to receive one share of common stock upon the vesting of the unit.